Antibiotic prophylaxis for urinary tract infections after removal of urinary catheter: Meta-analysis

BMJ (Online)

Volumn 346, Issue 7914, 2013, Pages

  Marschall, Jonas ^a,b   Carpenter, Christopher R ^a   Fowler, Susan ^a   Trautner, Barbara W ^c,d  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFOTAXIME; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; NITROFURANTOIN; PLACEBO;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BLADDER CATHETERIZATION; CATHETER REMOVAL; CONTROLLED CLINICAL TRIAL (TOPIC); HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SINGLE DRUG DOSE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; URINARY CATHETER; URINARY TRACT INFECTION; DEVICE REMOVAL; FEMALE; INDWELLING CATHETER; MALE; METHODOLOGY; MICROBIOLOGY; PRACTICE GUIDELINE; REVIEW;

ANTIBIOTIC PROPHYLAXIS; CATHETERS, INDWELLING; DEVICE REMOVAL; FEMALE; GUIDELINES AS TOPIC; HUMANS; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; URINARY CATHETERIZATION; URINARY CATHETERS; URINARY TRACT INFECTIONS;

MLCS; MLOWN;

EID: 84879704088     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f3147     Document Type: Article

References (37)

1. Saint S, Lipsky BA. Preventing catheter-related bacteriuria: should we? Can we? How? Arch Intern Med 1999;159:800-8. (Pubitemid 29200306)
2. Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis 2010;50:625-63.
3. Gould CV, Umscheid CA, Agarwal RK, Kuntz G, Pegues DA. CDC-HICPAC: Guideline for prevention of catheter-associated urinary tract infections. Centers for Disease Control and Prevention, 2009. www.cdc.gov/hicpac/cauti/001- cauti.html.
4. Lo E, Nicolle L, Classen D, Arias KM, Podgorny K, Anderson DJ, et al. Strategies to prevent catheter-associated urinary tract infections in acute care hospitals. Infect Control Hosp Epidemiol 2008;29(suppl 1):S41-50.
5. Cutter CS, Kelly SR, Marcello PW, Mahoney JE, Nicolle LE, McLeod RS. CAGS and ACS evidence based reviews in surgery. Is there a role for prophylactic antibiotics in the prevention of urinary tract infections following Foley catheter removal in patients having abdominal surgery? Can J Surg 2011;54:206-8.
6. Warren JW, Damron D, Tenney JH, Hoopes JM, Deforge B, Muncie HL Jr. Fever, bacteremia, and death as complications of bacteriuria in women with long-term urethral catheters. J Infect Dis 1987;155:1151-8. (Pubitemid 17080488)
7. Pfefferkorn U, Lea S, Moldenhauer J, Peterli R, von Flue M, Ackermann C. Antibiotic prophylaxis at urinary catheter removal prevents urinary tract infections: a prospective randomized trial. Ann Surg 2009;249:573-5.
8. Van Hees BC, Vijverberg PL, Hoorntje LE, Wiltink EH, Go PM, Tersmette M. Single-dose antibiotic prophylaxis for urinary catheter removal does not reduce the risk of urinary tract infection in surgical patients: a randomized double-blind placebo-controlled trial. Clin Microbiol Infect 2011;17:1091-4.
9. Wazait HD, van der Meullen J, Patel HR, Brown CT, Gadgil S, Miller RA, et al. Antibiotics on urethral catheter withdrawal: a hit and miss affair. J Hosp Infect 2004;58:297-302. (Pubitemid 39618897)
10. Wolf JS Jr, Bennett CJ, Dmochowski RR, Hollenbeck BK, Pearle MS, Schaeffer AJ. Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol 2008;179:1379-90.
11. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009;62:e1-34.
12. Trautner BW. Asymptomatic bacteriuria: when the treatment is worse than the disease. Nat Rev Urol 2012;9:85-93.
13. Higgins JP, Green S, eds. Formulating the problem. Cochrane handbook for systematic reviews of interventions. 4.2.6 [updated September 2006]. Section 6. Cochrane Library. John Wiley, 2006.
14. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;20:37-46.
15. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60. (Pubitemid 37088507)
16. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34. (Pubitemid 27387172)
17. Rogers RG, Kammerer-Doak D, Olsen A, Thompson PK, Walters MD, Lukacz ES, et al. A randomized, double-blind, placebo-controlled comparison of the effect of nitrofurantoin monohydrate macrocrystals on the development of urinary tract infections after surgery for pelvic organ prolapse and/or stress urinary incontinence with suprapubic catheterization. Am J Obstet Gynecol 2004;191:182-7. (Pubitemid 39077972)
18. Raz R, Almog D, Elhanan G, Shental J. The use of ceftriaxone in the prevention of urinary tract infection in patients undergoing transurethral resection of the prostate (TUR-P). Infection 1994;22:347-9. (Pubitemid 24316422)
19. Duclos JM, Larrouturou P, Sarkis P. Timing of antibiotic prophylaxis with cefotaxime for prostatic resection: better in the operative period or at urethral catheter removal? Am J Surg 1992;164(4A suppl):21-23S.
20. Conn IG, Moffat LE. Short-term cephradine prophylaxis in elective transurethral prostatectomy. J Hosp Infect 1988;11:373-5.
21. Sze EHM, Rosenzweig BA, Osborne NG, Baggish MS. Catheter-associated bacteriuria following gynecologic surgery. J Gynecol Surg 1989;5:171-6. (Pubitemid 19240018)
22. Van der Wall E, Verkooyen RP, Mintjes-de Groot J, Oostinga J, van Dijk A, Hustinx WN, et al. Prophylactic ciprofloxacin for catheter-associated urinary-tract infection. Lancet 1992;339:946-51.
23. Fox BC, Sollinger HW, Belzer FO, Maki DG. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim- sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis. Am J Med 1990;89:255-74. (Pubitemid 20323251)
24. Banks JA, McGuire BB, Loeb S, Shrestha S, Helfand BT, Catalona WJ. Bacteriuria and antibiotic resistance in catheter urine specimens following radical prostatectomy. Urol Oncol 2012, Jan 25 epub ahead of print.
25. Grabe M, Forsgren A, Hellsten S. A short antibiotic course given in conjunction with and after catheter removal consecutive to transurethral prostatic resection. Scand J Urol Nephrol 1984;18:193-9. (Pubitemid 14057642)
26. Harding GK, Nicolle LE, Ronald AR, Preiksaitis JK, Forward KR, Low DE, et al. How long should catheter-acquired urinary tract infection in women be treated? A randomized controlled study. Ann Intern Med 1991;114:713-9.
27. Wazait HD, Patel HR, van der Meulen JH, Ghei M, Al-Buheissi S, Kelsey M, et al. A pilot randomized double-blind placebo-controlled trial on the use of antibiotics on urinary catheter removal to reduce the rate of urinary tract infection: the pitfalls of ciprofloxacin. BJU Int 2004;94:1048-50. (Pubitemid 39577092)
28. Brandenburg A, Lingsma M, Terpstra S, Vd Mijle H, Ott A. Urinary tract infection after removal of urinary catheter; no effect of nitrofurantoin profylaxis. J Hosp Infect 2006;64(S1):S108.
29. Pinochet R, Nogueira L, Cronin AM, Katz D, Rabbani F, Guillonneau B, et al. Role of short-term antibiotic therapy at the moment of catheter removal after laparoscopic radical prostatectomy. Urol Int 2010;85:415-20.
30. Egger M, Smith GD, Altman DG. Systematic reviews in health care: meta-analysis in context. 2nd ed. BMJ Publishing, 2001.
31. Leuck AM, Wright D, Ellingson L, Kraemer L, Kuskowski MA, Johnson JR. Complications of Foley catheters - is infection the greatest risk? J Urol 2012;187:1662-6.
32. File TM Jr, Solomkin JS, Cosgrove SE. Strategies for improving antimicrobial use and the role of antimicrobial stewardship programs. Clin Infect Dis 2011;53(suppl 1):S15-22.
33. Wennberg DE. Variation in the delivery of health care: the stakes are high. Ann Intern Med 1998;128:866-8. (Pubitemid 28267722)
34. Cullen IM, Manecksha RP, McCullagh E, Ahmad S, O'Kelly F, Flynn RJ, et al. The changing pattern of antimicrobial resistance within 42,033 Escherichia coli isolates from nosocomial, community and urology patient-specific urinary tract infections, Dublin, 1999-2009. BJU Int 2012;109:1198-206.
35. Bakken JS. The fluoroquinolones: how long will their utility last? Scand J Infect Dis 2004;36:85-92. (Pubitemid 38313032)
36. Stewardson AJ, Huttner B, Harbarth S. At least it won't hurt: the personal risks of antibiotic exposure. Curr Opin Pharmacol 2011;11:446-52.
37. Fakih MG, Watson SR, Greene MT, Kennedy EH, Olmsted RN, Krein SL, et al. Reducing inappropriate urinary catheter use: a statewide effort. Arch Intern Med 2012;172:255-60. Excellence